CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-15). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2607 · Search date 2026-08-15 · Methodology v0.7

Preoperative carbohydrate drink,
does it really help with Attenuation of immediate postoperative insulin resistance?

30-Second Summary
C
Evidence Grade C · 50 · Safety caution
Postoperative insulin sensitivity was better preserved, but these were not trials of clinical recovery
No prominent major adverse-event signal appeared in the small studies of non-diabetic elective surgical patients. However, the two pivotal studies were not large enough to test aspiration, and patients at high aspiration risk were excluded, so the findings cannot be extrapolated to them. Diabetes, delayed gastric emptying, and aspiration risk require individualized anesthesia and surgical assessment.
What the
research shows
The grade is C with 50 points. Two very small randomized studies found postoperative insulin-sensitivity reductions of roughly 16% to 26% with carbohydrate versus 37% to 49% with placebo or fasting. The differences were large, but the outcome was a glucose-clamp biomarker, the investigator groups overlapped substantially, and the evidence cannot be extended to infection, length of stay, or recovery.
What the
ads claim
The regimen delivered 100 g the prior evening and 50 g two hours before anesthesia. Preserving a clamp measurement must be separated from claims of fewer complications or faster recovery.
*

Useful facts when choosing a product

  • The regimen used 800 mL the prior evening and 400 mL two hours pre-anesthesia, totaling 150 g carbohydrate.
  • The key endpoint was whole-body insulin sensitivity measured by a hyperinsulinemic normoglycemic clamp.
  • Substantial investigator overlap prevents counting the studies as independent replication.
Gap Measurement · Verdict 2607 · C 50
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Nygren 1999 randomized 16 hip-replacement patients to carbohydrate or placebo and separately compared 14 colorectal-surgery patients receiving carbohydrate or fasting. Soop 2001 double-blindly assigned 15 hip-replacement patients, 8 versus 7. Nygren, Soop, Thorell, and Ljungqvist overlap across the reports, so they are not independent replication. Funding and allocation concealment could not be confirmed in the accessible material.

02

Why this is classified as C (50)

The metabolic effect was at least medium by statistical convention, but only a surrogate was measured in tiny studies with overlapping investigators, giving C with 50 points.

Counterpoint. This applies to metabolic response in elective non-diabetic surgical patients; clinical recovery and diabetic safety are separate questions.

Rejudgment record. Cross-check applied — Cross-checked group sizes, dosing, clamp outcomes, author overlap, and reported effects in both original records

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Attenuation of immediate postoperative insulin resistanceCTwo small studies moved in the same metabolic direction.
Reduction in surgical complications?The pivotal studies did not test clinical complications.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Nygren J, Soop M, Thorell A, Sree Nair K, Ljungqvist O. 1999Randomized placebo-controlled hip component and carbohydrate-versus-fasting colorectal component7Funding not confirmed in accessible materialChange in clamp-measured insulin sensitivityHip -16% versus -37%; colorectal -26±8% versus -49±6%Early small metabolic-outcome evidence
Soop M, Nygren J, Myrenfors P, Thorell A, Ljungqvist O. 2001Double-blind randomized placebo-controlled trial7Funding not confirmed in accessible materialImmediate postoperative clamp-measured insulin sensitivity-18% versus -43%, P<0.05Small confirmatory trial with overlapping investigators
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-15).

Nygren J, Soop M, Thorell A, Sree Nair K, Ljungqvist O. Preoperative oral carbohydrates and postoperative insulin resistance. Clin Nutr. 1999;18(2):117-120. PMID: 10459075. DOI: 10.1054/clnu.1998.0019.
checked
Soop M, Nygren J, Myrenfors P, Thorell A, Ljungqvist O. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. Am J Physiol Endocrinol Metab. 2001;280(4):E576-E583. PMID: 11254464. DOI: 10.1152/ajpendo.2001.280.4.E576.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-15 · Corrections: none

Cite this verdict

Preoperative carbohydrate drink x postoperative insulin resistance Evidence Grade C card
[Chamgap] Preoperative carbohydrate drink x postoperative insulin resistance — Evidence Grade C·50. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/blood-sugar/preoperative-carbohydrate-drink-postoperative-insulin-resistance/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.